Nanomedicine : nanotechnology, biology, and medicine · 2021
Bi-functional gold nanocages enhance specific immunological responses of foot-and-mouth disease virus-like particles vaccine as a carrier and adjuvant.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Teng Zhidong, Sun Shiqi, Luo Xin, Zhang Zhihui, Seo Hoseong, Xu Xiaoyu, Huang Jie, Dong Hu, Mu Suyu, Du Ping, Zhang Zhijun, Guo Huichen
Аннотация
Virus-like particle (VLP) vaccines have become one of the dominant vaccine candidates for foot-and-mouth disease (FMD). To further enhance the immunogenicity of VLP vaccines, gold nanocages (AuNCs) were selected as an adjuvant for the vaccine. Our experiments demonstrated that AuNCs had little biotoxicity in vivo and in vitro and improved the uptake of VLP in BHK-21 and RAW264.7 cell lines. The VLP-AuNCs activated DCs mainly through toll-like receptor 4 (TLR4) and promoted the secretion of IL-6, IL-1β, and TNF-α. The conjugation of VLP and AuNCs triggered a strong immune response against FMD virus (FMDV) in mice and guinea pigs. The VLP-AuNCs significantly enhanced the proliferation of CD8+ T cells (P < 0.05) and the secretion of cellular immune-related cytokines (IFN-γ, P < 0.05; IL-12p70, P < 0.01) compared with VLP. The present study demonstrated that AuNCs, as a great potential adjuvant for FMDV VLP vaccines, significantly enhance the immune response.
Предметные рубрики MeSH
Adjuvants, ImmunologicAnimalsBiomedical EnhancementCD8-Positive T-LymphocytesCell Membrane PermeabilityCell ProliferationCytokinesDrug CarriersDrug CompoundingDrug LiberationFemaleFoot-and-Mouth DiseaseFoot-and-Mouth Disease VirusGoldGuinea PigsMetal NanoparticlesMiceMice, Inbred BALB CNeutralization TestsRAW 264.7 CellsVaccines, Virus-Like ParticleViral Vaccines